UK-based company Smith & Nephew has entered an agreement to buy Swiss optical tracking technology maker Atracsys Sarl for an undisclosed amount.
Initially, Smith & Nephew intends to use Atracsys’ optical tracking camera fusionTrack 500 in its next-generation robotics platform. The multi-asset digital surgery and robotic system is set for commercial launch next year.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Compared to existing tracking technology, fusionTrack 500 is said to offer a better measurement speed and latency performance, reduced procedure times and increased accuracy for finer surgical tasks such as bone cuts.
Smith & Nephew Orthopaedics global president Skip Kiil said: “The promise of computer-assisted surgery with robotics is to provide faster, more accurate, reproducible results that enable surgeons to restore quality of life to more patients.
“With the acquisition of Atracsys, we are securing what we believe to be the best-in-class position tracking technology for our next-generation robotic-assisted surgical system.”
Atracsys Sarl’s portfolio comprises open platform optical navigation and robotic tracking components for use in orthopaedics, neurosurgery, spine and dental therapeutic areas.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataAfter completion of the transaction, Smith & Nephew intends to continue catering to these markets.
Atracsys Sarl co-founder and chief technology officer Maurice Hälg said: “Smith & Nephew’s commitment to offer significant advancements in enabling technology across multiple surgical specialities will open breakthrough opportunities for robotics and computer-assisted surgery.”
The deal is scheduled to close during the third quarter of this year.
Earlier this month, Smith & Nephew completed the acquisition of Brainlab orthopaedic joint reconstruction business in a bid to drive multi-asset digital surgery and robotic technologies.
